Docking of T cell antigen receptors (TCRs) engaging complexes of peptide and major histocompatibility complex has shown the same diagonal orientation and polarity. A new study demonstrating that TCRs from regulatory T cells bind with reversed polarity challenges this dogma.
References
Beringer, T. et al. Nat. Immunol. 16, 1153–1161 (2015).
Attaf, M., Legut, M., Cole, D.K. & Sewell, A.K. Clin. Exp. Immunol. 181, 1–18 (2015).
Rangarajan, S. & Mariuzza, R.A. Cell. Mol. Life Sci. 71, 3059–3068 (2014).
Garcia, K.C. Trends Immunol. 33, 429–436 (2012).
Tungatt, K. et al. J. Immunol. 194, 463–474 (2015).
Cole, D.K. et al. J. Immunol. 178, 5727–5734 (2007).
Gagliani, N. et al. Nat. Med. 19, 739–746 (2013).
Tree, T.I. et al. Diabetes 59, 1451–1460 (2010).
Arif, S. et al. Diabetes 63, 3835–3845 (2014).
Arif, S. et al. J. Clin. Invest. 113, 451–463 (2004).
Gibson, V.B. et al. Clin. Exp. Immunol. doi:10.1111/cei.12687 (22 July 2015).
Thrower, S.L. et al. Clin. Exp. Immunol. 155, 156–165 (2009).
Burton, B.R. et al. Nat. Commun. 5, 4741 (2014).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
M.P. and King's College London have a license agreement with UCB Pharma to develop a peptide-based immunotherapy for type 1 diabetes.
Rights and permissions
About this article
Cite this article
Peakman, M., Sewell, A. Reversed-polarity Treg cell TCRs provide a shock. Nat Immunol 16, 1105–1107 (2015). https://doi.org/10.1038/ni.3289
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3289
- Springer Nature America, Inc.